For Release: October 20, 2004
Statement of the Federal Trade Commission Regarding the Decision to Close Its Investigation into the Conduct of Akzo Nobel, NV and Its Organon Subsidiary
The attorneys general of several states (the States) today announced their submission, for approval by the U.S. District Court for the District of New Jersey, of a settlement agreement with Akzo Nobel, N.V., and its subsidiary, Organon USA Inc. (collectively, Organon), resolving the States' allegations that Organon violated the antitrust laws by engaging in various anticompetitive acts relating to its anti-depressant drug, Remeron. More...
For Your Information:
Announced Actions for October 20, 2004
Commission authorization of the staff to file amended complaints: The Commission has authorized the staff to file an amended complaint in the currently pending matter concerning Chase Financial Funding, Inc., et al.
The Commission has authorized the staff to file an amended complaint in the currently pending matter concerning Pharmacycards.com, et al.
Application for proposed divestiture: The Commission has received an application from AspenTechnology, Inc. (AspenTech), requesting FTC approval to divest its Engineering Software Assets, as that term is defined in the Commission’s proposed order announced on July 15, 2004, to Honeywell International, Inc. More...
For Release: October 19, 2004
"Slim Down Solution": Problem Solved
A federal district court has permanently barred a group of marketers of bogus weight-loss products from making false claims about the effectiveness of their products. More...
Thursday, October 21, 2004 10:09 AM